Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,757.67
1,759.47
1,429.64
1,853.05
3,070.51
3,737.77
4,465.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,757.67
1,759.47
1,429.64
1,853.05
3,070.51
3,737.77
4,465.89
Raw Material Cost
381.06
362.26
309.05
290.81
343.37
368.32
387.33
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
42.03
160.58
198.00
246.42
245.68
238.24
248.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.19
2.97
3.08
3.46
4.28
3.23
0.36
Selling and Distribution Expenses
1,031.96
1,136.65
957.76
1,310.44
2,129.94
2,410.17
2,956.20
Other Expenses
10.15
-0.16
25.28
30.88
3.23
-2.03
2.73
Total Expenditure (Excl Depreciation)
1,557.70
1,660.85
1,720.72
2,159.98
2,755.55
2,999.64
3,619.95
Operating Profit (PBDIT) excl Other Income
200
98.6
-291.1
-306.90000000000003
315
738.1
845.9000000000001
Other Income
49.32
46.48
81.05
70.58
87.69
86.99
48.22
Operating Profit (PBDIT)
376.96
231.50
-125.24
-165.25
496.87
913.91
978.32
Interest
1.19
2.97
3.08
3.46
4.28
3.23
0.36
Exceptional Items
14.61
12.73
12.50
1.68
1.54
-0.26
-1.23
Gross Profit (PBDT)
1,376.60
1,397.21
1,120.59
1,562.24
2,727.14
3,369.44
4,078.56
Depreciation
133.99
92.18
87.42
97.86
98.55
94.57
88.80
Profit Before Tax
256.40
149.08
-203.25
-264.88
395.58
815.85
887.93
Tax
39.38
22.98
6.55
3.70
25.51
95.83
108.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
236.60
160.29
-148.53
-225.83
379.91
721.63
780.96
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
236.60
160.29
-148.53
-225.83
379.91
721.63
780.96
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-22.89
-31.82
-58.95
-40.38
0.66
3.74
-1.06
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
213.72
128.47
-207.48
-266.21
380.56
725.37
779.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,215.40
3,062.65
2,899.99
2,962.97
3,218.68
3,027.15
2,513.55
Earnings per share (EPS)
0.25
0.17
-0.16
-0.24
0.41
0.78
0.84
Diluted Earnings per share
0.25
0.17
-0.16
-0.24
0.41
0.78
0.84
Operating Profit Margin (Excl OI)
11.02%
5.28%
-20.54%
-18.01%
10.12%
19.59%
18.84%
Gross Profit Margin
22.21%
13.71%
-8.1%
-9.01%
16.09%
24.36%
21.87%
PAT Margin
13.46%
9.11%
-10.39%
-12.19%
12.37%
19.31%
17.49%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -0.10% vs 23.08% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 66.30% vs 161.93% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 77.08% vs 189.68% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -60.00% vs -3.23% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Beijing Aosaikang Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,757.67
0
1,757.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,757.67
0
1,757.67
Raw Material Cost
381.06
0
381.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
42.03
0
42.03
Power Cost
0
0
0.00
Manufacturing Expenses
1.19
0
1.19
Selling and Distribution Expenses
1,031.96
0
1,031.96
Other Expenses
10.15
0.00
10.15
Total Expenditure (Excl Depreciation)
1,557.70
0
1,557.70
Operating Profit (PBDIT) excl Other Income
199.97
0.00
199.97
Other Income
49.32
0
49.32
Operating Profit (PBDIT)
376.96
0
376.96
Interest
1.19
0
1.19
Exceptional Items
14.61
0
14.61
Gross Profit (PBDT)
1,376.60
0
1,376.60
Depreciation
133.99
0
133.99
Profit Before Tax
256.40
0
256.40
Tax
39.38
0
39.38
Provisions and contingencies
0
0
0.00
Profit After Tax
236.60
0
236.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
236.60
0
236.60
Share in Profit of Associates
0
0
0.00
Minority Interest
-22.89
0
-22.89
Other related items
0.00
0.00
0.00
Consolidated Net Profit
213.72
0
213.72
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,215.40
0
3,215.40
Earnings per share (EPS)
0.25
0
0.25
Diluted Earnings per share
0.25
0
0.25
Operating Profit Margin (Excl OI)
11.02%
0%
0.00
11.02%
Gross Profit Margin
22.21%
0%
0.00
22.21%
PAT Margin
13.46%
0%
0.00
13.46%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 175.77 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -0.10% vs 23.08% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 21.37 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 66.30% vs 161.93% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.76 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 77.08% vs 189.68% in Dec 2024
Annual - Interest
Interest 0.12 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -60.00% vs -3.23% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.02%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






